Aetna takes back colonoscopy cuts

Responding to a storm of criticism, Aetna has agreed to suspend its plan to stop paying for use of a strong anesthetic during colonoscopies. Aetna had announced that it would no longer pay for routine use of the drug propofol, which often is administered by an anesthesiologist. The health plan had said that it objected to the additional $300 to $1,000 needed for an anesthesiologist in the procedure, given that they didn't believe it improved outcomes. Critics, meanwhile, said that limiting propofol use would discourage patients from undergoing colonoscopies.

Aetna may have given way for now, but it hasn't given up its scrutiny of colonoscopies. It has said that it expects the FDA to approve new devices or drugs--such as a computer-assisted sedation device--as early as this summer, which will allow propofol to be administered without an anesthesiologist present. At that point it plans to rethink its colonoscopy coverage.

To learn more about Aetna's change of heart:
- read this piece in The New York Times

Related Articles:
Aetna, WellPoint refuse payment for serious errors. Report
MDs resisting Aetna colonoscopy anesthesia cuts. Report
Aetna, AMA fight over out-of-network payments. Report
Aetna strikes doctor-ratings deal with NY. Report
Aetna streamlines physician payments. Report
Aetna to disclose its physician prices online. Report
Aetna posts pricing, quality data. Report

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.